National Peroxide Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled to be held on Wednesday, November 11, 2026. The primary agenda item for the meeting is to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). The letter was signed by Akshay Rasikbhai Satasiya, who holds the position of Company Secretary and Compliance Officer for National Peroxide Limited. The digital signature was timestamped on November 05, 2026 at 13:45:33 +05:30.
No financial figures, results, or specific outcomes from the meeting are disclosed in this filing. The document serves solely as an intimation of the scheduled board meeting and its agenda.